Provided by Tiger Trade Technology Pte. Ltd.

United Therapeutics

513.12
-7.8800-1.51%
Post-market: 513.310.1900+0.04%19:30 EDT
Volume:415.57K
Turnover:215.18M
Market Cap:22.01B
PE:18.36
High:528.02
Open:523.23
Low:512.29
Close:521.00
52wk High:609.35
52wk Low:302.19
Shares:42.89M
Float Shares:39.35M
Volume Ratio:0.96
T/O Rate:1.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.95
EPS(LYR):27.86
ROE:19.31%
ROA:11.61%
PB:3.44
PE(LYR):18.42

Loading ...

United Therapeutics Says Pulmonary Arterial Hypertension Treatment Meets Primary Endpoint in Late-Stage Trial

MT Newswires Live
·
May 18

Baidu, Brady And 3 Stocks To Watch Heading Into Monday

Benzinga Earnings
·
May 18

TD Cowen Reaffirms Their Buy Rating on United Therapeutics (UTHR)

TIPRANKS
·
May 18

BRIEF-United Therapeutics Announces Advance Outcomes Study Of Ralinepag

Reuters
·
May 18

United Therapeutics says phase 3 ADVANCE OUTCOMES trial meets primary endpoint for ralinepag

Reuters
·
May 18

United Therapeutics Corp: Phase 3 Advance Outcomes Study Met Its Primary Endpoint

THOMSON REUTERS
·
May 18

United Therapeutics Corporation Announces Advance Outcomes Study of Ralinepag Presented at ATS 2026

THOMSON REUTERS
·
May 18

United Therapeutics wins FDA clearance for UHeart xenotransplant trial

Reuters
·
May 16

United Therapeutics Corp - Express Study to Enroll Initial Cohort of up to Two Participants

THOMSON REUTERS
·
May 16

United Therapeutics Corporation Announces FDA Clearance to Proceed With Uheart Xenotransplantation Clinical Trial

THOMSON REUTERS
·
May 16

United Therapeutics CEO Martine Rothblatt disposes of USD 6.96 million in shares

Reuters
·
May 16

United Therapeutics CFO James Edgemond sells 9,000 shares for $5,162,421.22

Reuters
·
May 16

United Therapeutics, Varda to Study Space-Based Drug Manufacturing for Pulmonary Disease Treatments

MT Newswires Live
·
May 13

Varda Space Industries and United Therapeutics Collaborate to Advance Microgravity-Enabled Treatments for Rare Pulmonary Disease

THOMSON REUTERS
·
May 13

United Therapeutics CEO Martine Rothblatt sells USD 2.66 million in shares

Reuters
·
May 13

United Therapeutics CFO James Edgemond sells USD 5.74 million common shares

Reuters
·
May 13

United Therapeutics CFO presents at RBC Capital Markets Global Healthcare Conference

Reuters
·
May 12

United Therapeutics CFO James Edgemond sells common shares worth $4.17 million

Reuters
·
May 11

United Therapeutics CEO Martine Rothblatt disposes of 8,225 shares for $4.78 million

Reuters
·
May 11

United Therapeutics to present positive data of treprostinil in IPF

TIPRANKS
·
May 11